Vasant R. Pai

505 total citations · 1 hit paper
10 papers, 371 citations indexed

About

Vasant R. Pai is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Vasant R. Pai has authored 10 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Vasant R. Pai's work include Acute Lymphoblastic Leukemia research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Vasant R. Pai is often cited by papers focused on Acute Lymphoblastic Leukemia research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Vasant R. Pai collaborates with scholars based in India, United States and Australia. Vasant R. Pai's co-authors include Jan B. Vermorken, Sylvie Rottey, B. Stein, Cristian Villanueva, Lisa Licitra, Kelly S. Oliner, Paolo Foa, Krzysztof Składowski, Arlene A. Forastiere and Bruce Allen Bach and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Vasant R. Pai

10 papers receiving 365 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

2013 314 citations Jan B. Vermorken, Ірина Давиденко et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Vasant R. Pai

Since Specialization

Citations

This map shows the geographic impact of Vasant R. Pai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasant R. Pai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasant R. Pai more than expected).

Fields of papers citing papers by Vasant R. Pai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasant R. Pai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasant R. Pai. The network helps show where Vasant R. Pai may publish in the future.

Co-authorship network of co-authors of Vasant R. Pai

This figure shows the co-authorship network connecting the top 25 collaborators of Vasant R. Pai. A scholar is included among the top collaborators of Vasant R. Pai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasant R. Pai. Vasant R. Pai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial breakdown → 2013 ·The Lancet Oncology ·Jan B. Vermorken, (unknown), Ірина Давиденко, Lisa Licitra, Eric Winquist, Cristian Villanueva, Paolo Foa, Sylvie Rottey, Krzysztof Składowski, Makoto Tahara, Vasant R. Pai, Sandrine Faivre, C. Blajman, Arlene A. Forastiere, B. Stein, Kelly S. Oliner, Zhiying Pan, Bruce Allen Bach	314
2	Lower Dose Dexamethasone/Thalidomide and Zoledronic Acid Every 3 Weeks in Previously Untreated Multiple Myeloma 2011 ·Clinical Lymphoma Myeloma & Leukemia ·Gerrard Teoh, Yu‐Ming Chen, Kihyun Kım, Alok Srivastava, Vasant R. Pai, Sung‐Soo Yoon, Cheolwon Suh, Yeo-Kyeoung Kim	4
3	Plasma Cell Dyscrasia Presenting As Ascites and Omental Mass 2008 ·Journal of Clinical Oncology ·Narayan Karanth, (unknown), (unknown), (unknown), Kumar Prabhash, Vasant R. Pai, Purvish M. Parikh, Sumeet Gujral	1
4	Survival of Childhood Acute Lymphoblastic Leukemia: Results of Therapy at Tata Memorial Hospital, Bombay, India 1996 ·Leukemia & lymphoma ·Sucheta Vaidya, Suresh H. Advani, Suresh K. Pai, Chandrika N. Nair, Purna Kurkure, (unknown), R. Gopal, Vasant R. Pai, (unknown), Purvish M. Parikh	19
5	Adult Acute Lymphoblastic Leukemia: Results of an Aggressive Regimen in India 1994 ·Leukemia & lymphoma ·Noopur Raje, Suresh K. Pai, Sucheta Vaidya, R. Gopal, Purvish M. Parikh, T. K. Saikia, Vasant R. Pai, (unknown), (unknown)	4
6	Phase II Study of High-Dose Ifosfamide as a Single Agent and in Combination with Cisplatin in the Treatment of Advanced and/or Recurrent Squamous Cell Carcinoma of Head and Neck 1993 ·Oncology ·Vasant R. Pai, Deepak M. Parikh, (unknown), Raja S. Rao	14
7	Adjuvant chemotherapy for osteogenic sarcoma of the extremity with sequential adriamycin and cisplatin 1993 ·Journal of Surgical Oncology ·Anand Pathak, Suresh H. Advani, (unknown), Suresh K. Pai, (unknown), (unknown), (unknown), Purna Kurkure, Chandrika N. Nair, Vasant R. Pai, (unknown), (unknown), (unknown), Constantine P. Karakousis	6
8	Continuous cyclophosphamide, doxorubicin, vincristine, and prednisolone. A new, innovative protocol for diffuse aggressive lymphomas 1990 ·Cancer ·Shripad Banavali, Suresh H. Advani, (unknown), Sanjiv S. Agarwala, (unknown), (unknown), Suresh K. Pai, (unknown), Chandrika N. Nair, (unknown), Shyam Kishore Shrivastava, (unknown), Vasant R. Pai, (unknown), (unknown)	1
9	The Pattern of Malignant Lymphoma in India: A Study of 1371 Cases 1990 ·Leukemia & lymphoma ·Suresh H. Advani, Shripad Banavali, Sanjiv S. Agarwala, (unknown), (unknown), Anita Borges, Tapan Saikia, Chandrika N. Nair, (unknown), Suresh K. Pai, Vasant R. Pai, (unknown), Shyam Kishore Shrivastava, (unknown), D. N. Rao	7
10	Liv.52 Therapy in Hypoproteinaemia 1972 ·Vasant R. Pai, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact